Found 0 matching trials
PEP-CMV + Nivolumab for Newly Diagnosed Diffuse Midline Glioma/High-grade Glioma and Recurrent Diffuse Midline Glioma/High-grade Glioma, Medulloblastoma, and Ependymoma PHASE1 This is a multisite, phase I/II clinical trial in children and young adults...
Show More Location
Washington University School of Medicine
Learn More & Join Trial
Nivolumab and Ipilimumab in Mucinous Colorectal and Appendiceal Tumors PHASE2 This is a single-arm phase II study of twenty-one subjects with mucinous ad...
Show More Location
Abramson Cancer Center of the University of Pennsylvania
Learn More & Join Trial
Phase 1b/2 Trial of Ipilimumab, Nivolumab, and Ciforadenant (Adenosine A2a Receptor Antagonist) in First-line Advanced Renal Cell Carcinoma. PHASE1 To learn if the combination of ciforadenant, ipilimumab, and nivolumab can ...
Show More Status
Active Not Recruiting
Location
Duke Cancer Institute
Learn More & Join Trial
Phase I Study of 131-I mIBG Followed by Nivolumab & Dinutuximab Beta Antibodies in Children With Relapsed/Refractory Neuroblastoma PHASE1 Neuroblastoma, the most common extra-cranial solid tumour in children, rema...
Show More Status
Active Not Recruiting
Location
University of Wisconsin Carbone Cancer Center; UW Hospital and Clinics; American Family Children's Hospital
Learn More & Join Trial
An Investigational Immuno-therapy Study to Evaluate Safety and Effectiveness in Patients With Melanoma That Has Spread to the Brain, Treated With Nivolumab in Combination With Ipilimumab, Followed by Nivolumab by Itself PHASE2 This is a study of Nivolumab combined with Ipilimumab followed by Nivolumab...
Show More Learn More & Join Trial
Autologous Hematopoietic Stem Cell Transplantation in Pediatric Relapsed or Refractory Hodgkin Lymphoma After Nivolumab Treatment PHASE2 Children with relapsed or refractory Hodgkin lymphoma receive 3-6 cycles of...
Show More Status
Enrolling By Invitation
Location
N. N. Blokhin Russian Cancer Research Center, Moscow, Russia
Learn More & Join Trial
Study of BMS-986158 in Subjects With Select Advanced Cancers PHASE1 The purpose of this study is to determine the safety, tolerability, pharmac...
Show More Location
City Of Hope National Medical Center
Learn More & Join Trial
Neoadjuvant Ipilimumab Plus Nivolumab Versus Standard Adjuvant Nivolumab in Macroscopic Stage III Melanoma PHASE3 This is an international (Australia, Europe, and USA) open-label two-arm ra...
Show More Status
Active Not Recruiting
Location
The Angeles Clinic
Learn More & Join Trial
A Pilot Study of Perioperative Nivolumab and Paricalcitol to Target the Microenvironment in Resectable Pancreatic Cancer EARLY_PHASE1 The main purpose of this study is to look at the potential effects of paric...
Show More Location
Abramson Cancer Center of the University of Pennsylvania
Learn More & Join Trial
Nivolumab Combined With Ipilimumab for Patients With Advanced Rare Genitourinary Tumors PHASE2 This research study is studying a combination of drugs as a possible treatm...
Show More Status
Active Not Recruiting
Location
University of California, San Diego Moores Cancer Center
Learn More & Join Trial